Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anti-Bacterial Agents | 11 | 2023 | 739 | 2.180 |
Why?
|
Fever | 3 | 2021 | 125 | 1.660 |
Why?
|
Candidiasis | 2 | 2023 | 36 | 1.490 |
Why?
|
Drug Utilization | 2 | 2018 | 65 | 1.200 |
Why?
|
Antimicrobial Stewardship | 4 | 2021 | 21 | 1.170 |
Why?
|
Antibiotic Prophylaxis | 3 | 2020 | 69 | 1.010 |
Why?
|
Febrile Neutropenia | 2 | 2021 | 14 | 0.970 |
Why?
|
Pharmacy | 1 | 2023 | 7 | 0.950 |
Why?
|
Staphylococcal Infections | 2 | 2023 | 255 | 0.900 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 73 | 0.880 |
Why?
|
Meningitis, Aseptic | 1 | 2022 | 8 | 0.850 |
Why?
|
Enterovirus | 1 | 2022 | 34 | 0.850 |
Why?
|
Bacteremia | 3 | 2020 | 99 | 0.840 |
Why?
|
Enterovirus Infections | 1 | 2022 | 40 | 0.840 |
Why?
|
Meningitis | 1 | 2022 | 20 | 0.840 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 151 | 0.830 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2022 | 46 | 0.810 |
Why?
|
Respiratory Tract Infections | 3 | 2018 | 104 | 0.770 |
Why?
|
Neutropenia | 2 | 2020 | 215 | 0.750 |
Why?
|
Stem Cell Transplantation | 1 | 2021 | 183 | 0.750 |
Why?
|
Organ Transplantation | 2 | 2021 | 263 | 0.730 |
Why?
|
Hypersensitivity | 1 | 2020 | 153 | 0.690 |
Why?
|
Drug Packaging | 1 | 2018 | 7 | 0.680 |
Why?
|
Medication Errors | 1 | 2019 | 39 | 0.680 |
Why?
|
Neutrophils | 1 | 2020 | 306 | 0.670 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2019 | 64 | 0.660 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 429 | 0.630 |
Why?
|
Guideline Adherence | 2 | 2017 | 222 | 0.620 |
Why?
|
Candida | 1 | 2016 | 17 | 0.570 |
Why?
|
Chemotherapy-Induced Febrile Neutropenia | 1 | 2016 | 6 | 0.570 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2020 | 878 | 0.570 |
Why?
|
Blood Culture | 1 | 2016 | 11 | 0.570 |
Why?
|
Escherichia coli Infections | 1 | 2016 | 35 | 0.550 |
Why?
|
Retrospective Studies | 12 | 2023 | 8431 | 0.540 |
Why?
|
Electronic Health Records | 1 | 2019 | 319 | 0.530 |
Why?
|
Pneumococcal Vaccines | 1 | 2015 | 28 | 0.520 |
Why?
|
Oseltamivir | 1 | 2015 | 20 | 0.520 |
Why?
|
Social Media | 1 | 2016 | 78 | 0.520 |
Why?
|
Streptococcus pneumoniae | 1 | 2015 | 48 | 0.510 |
Why?
|
Pneumococcal Infections | 1 | 2015 | 46 | 0.510 |
Why?
|
Pneumonia | 1 | 2016 | 178 | 0.500 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 69 | 0.500 |
Why?
|
Virus Diseases | 1 | 2015 | 96 | 0.490 |
Why?
|
Viruses | 1 | 2015 | 78 | 0.490 |
Why?
|
Education, Medical | 1 | 2016 | 231 | 0.470 |
Why?
|
Escherichia coli | 1 | 2016 | 596 | 0.450 |
Why?
|
Humans | 31 | 2023 | 86281 | 0.440 |
Why?
|
Antiviral Agents | 2 | 2021 | 508 | 0.430 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 508 | 0.420 |
Why?
|
Leukocyte Count | 2 | 2023 | 220 | 0.420 |
Why?
|
Surgical Wound Infection | 3 | 2020 | 183 | 0.400 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 636 | 0.400 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 2434 | 0.400 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 316 | 0.390 |
Why?
|
HIV Infections | 1 | 2019 | 768 | 0.370 |
Why?
|
Vancomycin | 2 | 2023 | 72 | 0.370 |
Why?
|
Neoplasms | 2 | 2021 | 2889 | 0.330 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 1030 | 0.330 |
Why?
|
Child, Preschool | 3 | 2021 | 3608 | 0.330 |
Why?
|
Geriatric Assessment | 2 | 2019 | 166 | 0.290 |
Why?
|
Chemical and Drug Induced Liver Injury | 2 | 2017 | 68 | 0.290 |
Why?
|
Antifungal Agents | 2 | 2017 | 117 | 0.280 |
Why?
|
Disease Management | 2 | 2019 | 327 | 0.280 |
Why?
|
Aged | 14 | 2022 | 18353 | 0.270 |
Why?
|
Chicago | 2 | 2021 | 1377 | 0.260 |
Why?
|
Child | 4 | 2021 | 6913 | 0.260 |
Why?
|
Female | 16 | 2022 | 44405 | 0.260 |
Why?
|
Laryngeal Neoplasms | 2 | 2016 | 89 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 301 | 0.260 |
Why?
|
Immunocompromised Host | 2 | 2023 | 140 | 0.260 |
Why?
|
Adolescent | 5 | 2021 | 8968 | 0.250 |
Why?
|
Transplant Recipients | 3 | 2021 | 120 | 0.250 |
Why?
|
Hospitalization | 2 | 2020 | 844 | 0.240 |
Why?
|
Transplantation, Homologous | 3 | 2021 | 996 | 0.240 |
Why?
|
Adult | 9 | 2023 | 25577 | 0.220 |
Why?
|
Immunotherapy, Adoptive | 1 | 2023 | 170 | 0.210 |
Why?
|
Multiplex Polymerase Chain Reaction | 3 | 2018 | 33 | 0.210 |
Why?
|
Lactams | 1 | 2020 | 10 | 0.200 |
Why?
|
beta-Lactams | 1 | 2020 | 14 | 0.190 |
Why?
|
Syndrome | 1 | 2021 | 446 | 0.190 |
Why?
|
Invasive Fungal Infections | 1 | 2020 | 10 | 0.190 |
Why?
|
Medical Overuse | 1 | 2020 | 36 | 0.190 |
Why?
|
C-Reactive Protein | 1 | 2020 | 190 | 0.180 |
Why?
|
Male | 13 | 2021 | 40860 | 0.180 |
Why?
|
Respiratory System | 1 | 2020 | 116 | 0.180 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2020 | 99 | 0.180 |
Why?
|
Patient Transfer | 1 | 2020 | 91 | 0.180 |
Why?
|
Bordetella Infections | 1 | 2018 | 5 | 0.170 |
Why?
|
Pharmacists | 1 | 2019 | 32 | 0.170 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 130 | 0.170 |
Why?
|
Pharmacy Service, Hospital | 1 | 2018 | 9 | 0.170 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2018 | 13 | 0.170 |
Why?
|
Osmolar Concentration | 1 | 2018 | 181 | 0.170 |
Why?
|
Recurrence | 1 | 2021 | 1137 | 0.170 |
Why?
|
Medical Audit | 1 | 2018 | 41 | 0.170 |
Why?
|
Levofloxacin | 1 | 2018 | 7 | 0.160 |
Why?
|
Tertiary Care Centers | 1 | 2018 | 93 | 0.160 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 1680 | 0.160 |
Why?
|
Drug Compounding | 1 | 2018 | 77 | 0.150 |
Why?
|
Diagnostic Errors | 1 | 2018 | 160 | 0.150 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 103 | 0.150 |
Why?
|
Preoperative Care | 1 | 2019 | 390 | 0.150 |
Why?
|
Delayed-Action Preparations | 1 | 2017 | 116 | 0.150 |
Why?
|
Patient Care Team | 1 | 2019 | 280 | 0.150 |
Why?
|
Middle Aged | 11 | 2020 | 24957 | 0.150 |
Why?
|
Triazoles | 1 | 2017 | 96 | 0.150 |
Why?
|
Drug Resistance, Microbial | 1 | 2016 | 72 | 0.150 |
Why?
|
Itraconazole | 1 | 2016 | 11 | 0.150 |
Why?
|
Empirical Research | 1 | 2016 | 19 | 0.150 |
Why?
|
Follow-Up Studies | 2 | 2021 | 3616 | 0.140 |
Why?
|
Microbiological Techniques | 1 | 2016 | 24 | 0.140 |
Why?
|
Histocytochemistry | 1 | 2016 | 130 | 0.140 |
Why?
|
RNA, Ribosomal | 1 | 2016 | 60 | 0.140 |
Why?
|
Liver Failure, Acute | 1 | 2016 | 38 | 0.140 |
Why?
|
DNA, Fungal | 1 | 2016 | 57 | 0.140 |
Why?
|
Paramyxoviridae | 1 | 2015 | 10 | 0.140 |
Why?
|
Autopsy | 1 | 2016 | 116 | 0.140 |
Why?
|
Arrhythmias, Cardiac | 1 | 2017 | 187 | 0.140 |
Why?
|
Risk Factors | 4 | 2020 | 5397 | 0.140 |
Why?
|
Prognosis | 2 | 2021 | 3669 | 0.140 |
Why?
|
Inpatients | 1 | 2019 | 295 | 0.140 |
Why?
|
Fatal Outcome | 1 | 2016 | 293 | 0.140 |
Why?
|
Infant, Newborn | 1 | 2021 | 2369 | 0.130 |
Why?
|
Community-Acquired Infections | 1 | 2015 | 63 | 0.130 |
Why?
|
Quality of Health Care | 1 | 2019 | 380 | 0.130 |
Why?
|
Laryngectomy | 1 | 2015 | 26 | 0.130 |
Why?
|
Fungi | 1 | 2015 | 65 | 0.130 |
Why?
|
Surgical Wound Dehiscence | 1 | 2015 | 37 | 0.130 |
Why?
|
Immunization, Secondary | 1 | 2015 | 30 | 0.130 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2020 | 929 | 0.130 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 39 | 0.130 |
Why?
|
Cystectomy | 1 | 2015 | 93 | 0.130 |
Why?
|
Infant | 1 | 2021 | 3036 | 0.130 |
Why?
|
Anti-Infective Agents | 1 | 2015 | 88 | 0.130 |
Why?
|
Incidence | 2 | 2016 | 1568 | 0.130 |
Why?
|
Advisory Committees | 1 | 2015 | 90 | 0.130 |
Why?
|
Early Diagnosis | 1 | 2015 | 131 | 0.120 |
Why?
|
Referral and Consultation | 1 | 2017 | 326 | 0.120 |
Why?
|
Cohort Studies | 1 | 2020 | 2759 | 0.120 |
Why?
|
Transplantation Conditioning | 1 | 2015 | 373 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2015 | 347 | 0.120 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 853 | 0.110 |
Why?
|
United States | 3 | 2021 | 6637 | 0.100 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2015 | 376 | 0.100 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2018 | 755 | 0.100 |
Why?
|
Time Factors | 2 | 2020 | 5198 | 0.090 |
Why?
|
Lung | 1 | 2016 | 1167 | 0.090 |
Why?
|
Surveys and Questionnaires | 1 | 2016 | 2495 | 0.080 |
Why?
|
Betacoronavirus | 2 | 2020 | 258 | 0.080 |
Why?
|
Postoperative Complications | 1 | 2015 | 2183 | 0.070 |
Why?
|
Pandemics | 2 | 2020 | 739 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2019 | 6481 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 1796 | 0.060 |
Why?
|
Adenosine Monophosphate | 1 | 2021 | 27 | 0.050 |
Why?
|
Alanine | 1 | 2021 | 85 | 0.050 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 17 | 0.050 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 73 | 0.050 |
Why?
|
Skilled Nursing Facilities | 1 | 2020 | 41 | 0.050 |
Why?
|
Health Planning Guidelines | 1 | 2019 | 24 | 0.050 |
Why?
|
Drug Monitoring | 1 | 2020 | 118 | 0.050 |
Why?
|
Coinfection | 1 | 2020 | 58 | 0.050 |
Why?
|
Disease Outbreaks | 1 | 2020 | 154 | 0.040 |
Why?
|
Health Plan Implementation | 1 | 2019 | 56 | 0.040 |
Why?
|
Bordetella bronchiseptica | 1 | 2018 | 6 | 0.040 |
Why?
|
Standard of Care | 1 | 2019 | 78 | 0.040 |
Why?
|
Bordetella pertussis | 1 | 2018 | 15 | 0.040 |
Why?
|
Cross Reactions | 1 | 2018 | 106 | 0.040 |
Why?
|
Dementia | 1 | 2020 | 187 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2019 | 328 | 0.040 |
Why?
|
False Positive Reactions | 1 | 2018 | 216 | 0.040 |
Why?
|
Tissue Donors | 1 | 2021 | 462 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 877 | 0.040 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 339 | 0.040 |
Why?
|
DNA, Bacterial | 1 | 2018 | 236 | 0.040 |
Why?
|
Palliative Care | 1 | 2019 | 256 | 0.040 |
Why?
|
Serum | 1 | 2017 | 25 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2017 | 93 | 0.040 |
Why?
|
Clinical Decision-Making | 1 | 2019 | 255 | 0.040 |
Why?
|
Lung Diseases, Fungal | 1 | 2016 | 17 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 1958 | 0.040 |
Why?
|
Histoplasmosis | 1 | 2016 | 25 | 0.040 |
Why?
|
Critical Pathways | 1 | 2016 | 35 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2020 | 7949 | 0.040 |
Why?
|
Prevalence | 1 | 2020 | 1239 | 0.040 |
Why?
|
Tablets | 1 | 2017 | 116 | 0.030 |
Why?
|
Patient Selection | 1 | 2019 | 685 | 0.030 |
Why?
|
Young Adult | 2 | 2017 | 5961 | 0.030 |
Why?
|
Electrocardiography | 1 | 2017 | 478 | 0.030 |
Why?
|
Graft vs Host Disease | 1 | 2015 | 364 | 0.030 |
Why?
|
Survival Analysis | 1 | 2017 | 1536 | 0.030 |
Why?
|
Age Factors | 1 | 2015 | 1842 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 977 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2015 | 1932 | 0.020 |
Why?
|
Practice Patterns, Physicians' | 1 | 2015 | 578 | 0.020 |
Why?
|